Former Celgene Corp. general counsel Jonathan Biller has found a new home as Bristol-Myers Squibb Co. wraps up its acquisition of his ex-employer.
Agios Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, announced Nov. 25 its hire of Biller as chief legal officer.
Biller’s hire comes a little more than a week after the Federal Trade Commission approved Bristol-Myers Squibb’s $74 billion acquisition of Celgene. The blockbuster deal, announced on Jan. 3 of this year, kicked off a frenzy of pharmaceutical industry mega-mergers and makes Bristol-Myers one of the world’s largest manufacturers of cancer drugs and treatments.
Summit, N.J.-based Celgene promoted ...